Dudley & Shanley’s Medtronic MDT Stock Holding History

Dudley & Shanley’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-223,165	Closed	-$20M	–	32
2022 Q2	$20M	Sell	223,165 -3,900	-2%	-$395K	4.49%	11
2022 Q1	$25.2M	Hold	227,065	–	–	4.69%	10
2021 Q4	$23.5M	Sell	227,065 -7,395	-3%	-$856K	4.07%	13
2021 Q3	$29.4M	Sell	234,460 -9,875	-4%	-$1.28M	5.17%	7
2021 Q2	$30.3M	Sell	244,335 -13,860	-5%	-$1.74M	5%	6
2021 Q1	$30.5M	Sell	258,195 -6,035	-2%	-$707K	5.26%	7
2020 Q4	$31M	Buy	264,230 +190,015	+256%	+$20.9M	5.7%	5
2020 Q3	$7.71M	Sell	74,215 -26,000	-26%	-$2.61M	1.87%	16
2020 Q2	$9.19M	Sell	100,215 -148,500	-60%	-$14.2M	2.54%	14
2020 Q1	$22.4M	Buy	248,715 +92,390	+59%	+$9.83M	5.64%	10
2019 Q4	$17.7M	Buy	+156,325	New	+$17.2M	4%	15

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dudley & Shanley's MDT Position: Q3 2022 in Review

Dudley & Shanley sold out of Medtronic (MDT) in Q3 2022, closing a stake of 223,165 shares — an estimated $20M sold.

Dudley & Shanley first reported a position in MDT in Q4 2019 and held it in 11 quarters. The position peaked at $31M in Q4 2020. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

Dudley & Shanley reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
Dudley & Shanley sold 223,165 Medtronic shares in Q3 2022, an estimated $20M.
Dudley & Shanley first reported a position in Medtronic in Q4 2019 and held it in 11 quarters.
Dudley & Shanley's Medtronic position peaked at $31M in Q4 2020.
1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Dudley & Shanley's 13F filing for Q3 2022, filed 18 Oct 2022.